Lung Cancer Fact Sheet
| MARKET FOCUS: |
United
States: According to the Center
for Disease Control, there are 94 million past and current
smokers in the US; there are 19 million smokers over the age
of 45 (the age at which lung cancer incidences increase).
Lung cancer claims nearly 200,000 victims each year in the
U.S., and is the most common cause of cancer death among men
and women. Twenty five percent of Americans smoke, and lung
cancer has grown 111% over 30 years. On an average day, 471
Americans are diagnosed with lung cancer, and, of the 471
diagnosed, 420 will die – a dismal 15% survival rate. Early
detection could raise the survival rate to approximately 85
percent.
China: China
has approximately 500 million people in a high-risk
category. Lung cancer is impacting the labor force – key
employees are dying. Treatment costs are high, and the
survival rate is below the 15% U.S. survival rate. The World
Health Organization has predicted that, of the 300 million
young men in the current population in China, 100 million of
them will die prematurely as a result of smoking-related
illnesses.
- Cigarette consumption in China is
increasing at the rate of 11% per year.
- Lung cancer rates in China are
increasing by 4.5% per year. By 2025, it is estimated that
2 million Chinese will die from smoking-related illnesses.
Korea: The
Korean market is such that it can be approached immediately,
in a very straightforward manner, with minimal overhead
costs. Korea currently use the Saccomano method for slide
preparation and staining, and has all equipment necessary to
begin the TCPP diagnostic process. BioModa has entered into
a Marketing and Distribution Agreement with Joseph Trading,
Inc. of Korea (JTI) with minimum purchase requirements for
BioModa’s proprietary and trade secret protected sample
preparation and staining techniques, and TCPP.
Other Potential Markets:
Japan, India, other Pacific Rim countries, Latin America,
Africa, and the European Union, represent other potential
market opportunities. |
| LUNG CANCER
FACTS: |
- According to the American Cancer
Society, lung cancer kills approximately 1 million people
worldwide and is the leading cause of cancer deaths in the
U.S.
- Smoking is responsible for nearly 90%
of the cancer deaths
- The incidence of lung cancer continues
to rise. It is currently the most fatal cancer malignancy
found among men and women in the U.S. and was the most
common cause of death in both sexes in 1995 (157,400
deaths).
- Lung cancer kills women at a rate of
11:1 when compared to the number of women who die from
cervical cancer each year.
- Lung cancer primarily strikes people
over age 45, and due to a lack of effective screening, is
usually spread by the time that it is diagnosed.
- Global cigarette production during the
past 20 years has increased an average of 2.2% per year.
- The majority of new cigarette consumers
are U.S. minorities such as Hispanics, African-Americans
and Native Americans, and people in Third-World developing
countries.
|
| LUNG CANCER
SYMPTOMS: |
There are rarely
symptoms in the early stages of lung cancer. Advanced stages
include coughing, wheezing, hoarseness, chest pain, weight
loss, swelling in neck and feet and coughing up blood.
|
| LUNG CANCER
TYPES: |
There are two
primary types of lung cancer:
Nonsmall Cell Carcinoma: Includes squamous,
adenocarcinoma and large cell carcinoma
Small Cell Carcinoma: Also known as "oat" cell
carcinoma, small cell carcinoma accounts for 20% of lung
cancer and spreads rapidly.
|
| A DIRECT LINK
BETWEEN CIGARETTES AND LUNG CANCER: |
90% of lung
cancer cases are directly linked to smoking. Other risk
factors that contribute, particularly in combination with
smoking, include exposure to such environmental toxins as
radon, asbestos, uranium and heredity. The likelihood of
developing lung cancer is directly related to the number of
cigarettes smoked over time. |
| EARLY
DETECTION MAKES A DIFFERENCE: |
- Analysis of sputum samples involves a
process very similar to that used in pap smears. Other
methods for detecting lung cancer include X-ray, sputum
analysis, lung biopsy and the use of MRI or CAT
scans to locate growths.
- Only 16% of lung cancer cases are
discovered early, yet the difference in five-year survival
rates is 46% for cases identified early while the disease
is still localized, versus 13% for late-stage cancer
diagnosis.
|
| LUNG CANCER
TREATMENT: |
- Surgery –
To remove portions of the cancerous lung.
- Radiation –
A beam of radiation is aimed directly at the cancer site
to destroy the tumor.
- Chemotherapy –
Uses drugs to systematically kill cancer
cells throughout the body.
- Promising Drug Therapies – Two drugs,
paclitaxel (Taxol) and vinrelbine (navelbine),
look very promising in the treatment of lung cancer,
making screening and early detection that much more
important.
|
|
|
|
|
|